Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice

Behavioural Brain Research

Volumn 166, Issue 1, 2006, Pages 131-139

  Ripoll, Nadège ^a   Hascoët, Martine ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

5 HT2 ligands; Anxiety; Four plates test; Mouse; Test experience

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; BW 723 C 86; DIAZEPAM; EPLIVANSERIN; RECEPTOR SUBTYPE; RS 10 2221; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; UNCLASSIFIED DRUG; 1 (5 (2 THENYLOXY) 1H INDOL 3 YL)PROPAN 2 AMINE; 1-(5-(2-THENYLOXY)-1H-INDOL-3-YL)PROPAN-2-AMINE; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; 8 [4 (5 AMINO 2,4 DIMETHOXYBENZOYL)BUTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; AMPHETAMINE DERIVATIVE; INDOLE DERIVATIVE; PROTEIN SUBUNIT; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SPIRO COMPOUND; SULFONAMIDE; THIOPHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; COMPARATIVE STUDY; DOSE RESPONSE; DRUG INTERACTION; PHYSIOLOGY; REPRODUCIBILITY;

AMPHETAMINES; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INDOLES; MALE; MICE; PROTEIN SUBUNITS; RECEPTORS, SEROTONIN; REPRODUCIBILITY OF RESULTS; SEROTONIN AGONISTS; SPIRO COMPOUNDS; SULFONAMIDES; THIOPHENES;

EID: 27944470411     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.07.013     Document Type: Article

References (86)

1. W.M. Abi-Saab, M. Bubser, R.H. Roth, and A.Y. Deutch 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex Neuropsychopharmacology 20 1999 92 96
2. R. Adamec, K. Creamer, G.D. Bartoszyk, and P. Burton Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats Eur J Pharmacol 504 2004 79 96
3. C. Aron, P. Simon, C. Larousse, and J.R. Boissier Evaluation of a rapid technique for detecting minor tranquilizers Neuropharmacology 10 1971 459 469
4. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
5. G. Baxter, G. Kennett, F. Blaney, and T. Blackburn 5-HT2 receptor subtypes: a family re-united? Trends Pharmacol Sci 16 1995 105 110
6. J.R. Boissier, P. Simon, and C. Aron A new method for rapid screening of minor tranquillizers in mice Eur J Pharmacol 4 1968 145 151
7. D.W. Bonhaus, C.L. Rocha, M.W. Dawson, and R.M. Eglen Absorption and brain penetration of a high affinity, highly selective 5-HT2C receptor antagonist, RS-102221 Ann N Y Acad Sci 861 1998 269
8. D.W. Bonhaus, K.K. Weinhardt, M. Taylor, A. DeSouza, P.M. McNeeley, and K. Szczepanski RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist Neuropharmacology 36 1997 621 629
9. A. Bortolozzi, M. Amargos-Bosch, A. Adell, L. Diaz-Mataix, J. Serrats, and S. Pons In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs Eur J Neurosci 18 2003 1235 1246
10. M. Bourin, F. Masse, E. Dailly, and M. Hascoët Anxiolytic-like effect milnacipran in the four-plate test in mice: mechanism of action Pharmacol Biochem Behav 81 2005 645 656
11. V.M. Castilho, C.E. Macedo, and M.L. Brandao Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats Psychopharmacol (Berl) 165 2002 77 85
12. F. Chaouloff, V. Baudrie, and I. Coupry Effects of chlorisondamine and restraint on cortical [3H]ketanserin binding, 5-HT2A receptor-mediated head shakes, and behaviours in models of anxiety Neuropharmacology 33 1994 449 456
13. C. Chiang, and G. Aston-Jones A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons Neuroscience 54 1993 409 420
14. V. Cornea-Hebert, M. Riad, C. Wu, S.K. Singh, and L. Descarries Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat J Comp Neurol 409 1999 187 209
15. N.V. Cozzi, and D.E. Nichols 5-HT2A receptor antagonists inhibit potassium-stimulated gamma-aminobutyric acid release in rat frontal cortex Eur J Pharmacol 309 1996 25 31
16. M.D. Doherty, and V.M. Pickel Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area Brain Res 864 2000 176 185
17. N.W. Dunham, and T.S. Miya A note on a simple apparatus for detecting neurological deficit in rats and mice J Am Pharm Assoc Am Pharm Assoc (Baltim) 46 1957 208 209
18. M.S. Duxon, G.A. Kennett, S. Lightowler, T.P. Blackburn, and K.C. Fone Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat Neuropharmacology 36 1997 601 608
19. Y. Dwivedi, A.C. Mondal, G.V. Payappagoudar, and H.S. Rizavi Differential regulation of serotonin (5HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior Neuropharmacology 48 2005 204 214
20. S.E. File, N. Andrews, P.Y. Wu, A. Zharkovsky, and H. Zangrossi Jr. Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience Eur J Pharmacol 218 1992 9 14
21. S.E. File, L.E. Gonzalez, and R. Gallant Role of the basolateral nucleus of the amygdala in the formation of a phobia Neuropsychopharmacology 19 1998 397 405
22. S.E. File, P.S. Mabbutt, and P.K. Hitchcott Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze Psychopharmacol (Berl) 102 1990 98 101
23. S.E. File, and H. Zangrossi Jr. One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacol (Berl) 110 1993 240 244
24. R. Gaggi, R. Dall'Olio, and P. Roncada Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats Gen Pharmacol 28 1997 583 587
25. A. Gobert, and M.J. Millan Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats Neuropharmacology 38 1999 315 317
26. F.G. Graeff, C.F. Netto, and H. Zangrossi Jr. The elevated T-maze as an experimental model of anxiety Neurosci Biobehav Rev 23 1998 237 246
27. G. Griebel, G. Perrault, and D.J. Sanger A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety Neuropharmacology 36 1997 793 802
28. G. Griebel, R.J. Rodgers, G. Perrault, and D.J. Sanger Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test Pharmacol Biochem Behav 57 1997 817 827
29. J.L. Griffiths, and T.A. Lovick Co-localization of 5-HT 2A-receptor- and GABA-immunoreactivity in neurones in the periaqueductal grey matter of the rat Neurosci Lett 326 2002 151 154
30. A.C. Grobin, and A.Y. Deutch Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat J Pharmacol Exp Ther 285 1998 350 357
31. J.A. Harvey Role of the serotonin 5-HT(2A) receptor in learning Learn Mem 10 2003 355 362
32. M. Hascoet, M. Bourin, M.C. Colombel, A.J. Fiocco, and G.B. Baker Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice Pharmacol Biochem Behav 65 2000 339 344
33. M. Hascoet, M. Bourin, and A. Couetoux du Tertre Influence of prior experience on mice behavior using the four-plate test Pharmacol Biochem Behav 58 1997 1131 1138
34. S. Hashimoto, T. Inoue, and T. Koyama Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats Eur J Pharmacol 378 1999 23 30
35. A. Holmes Targeted gene mutation approaches to the study of anxiety-like behavior in mice Neurosci Biobehav Rev 25 2001 261 273
36. A. Holmes, and R.J. Rodgers Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze Neurosci Biobehav Rev 23 1999 971 980
37. A. Holmes, and R.J. Rodgers Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacol Biochem Behav 60 1998 473 488
38. J. Ichikawa, H. Ishii, S. Bonaccorso, W.L. Fowler, I.A. O'Laughlin, and H.Y. Meltzer 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release J Neurochem 76 2001 1521 1531
39. T. Izumi, K. Suzuki, T. Inoue, X.B. Li, Y. Maki, and I. Muraki Long-lasting change in 5-HT2A receptor-mediated behavior in rats after a single footshock Eur J Pharmacol 452 2002 199 204
40. R.L. Jakab, and P.S. Goldman-Rakic 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites Proc Natl Acad Sci USA 95 1998 735 740
41. R.L. Jakab, and P.S. Goldman-Rakic Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex J Comp Neurol 417 2000 337 348
42. F. Jenck, J.L. Moreau, H.H. Berendsen, M. Boes, C.L. Broekkamp, and J.R. Martin Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats Eur Neuropsychopharmacol 8 1998 161 168
43. G. Kennett, S. Lightowler, B. Trail, F. Bright, and S. Bromidge Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety Eur J Pharmacol 387 2000 197 204
44. G.A. Kennett, F. Bright, B. Trail, G.S. Baxter, and T.P. Blackburn Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety Br J Pharmacol 117 1996 1443 1448
45. G.A. Kennett, K. Pittaway, and T.P. Blackburn Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety Psychopharmacol (Berl) 114 1994 90 96
46. G.A. Kennett, B. Trail, and F. Bright Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated Neuropharmacology 37 1998 1603 1610
47. G.A. Kennett, M.D. Wood, F. Bright, J. Cilia, D.C. Piper, and T. Gager In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties Br J Pharmacol 117 1996 427 434
48. Q. Li, C.H. Wichems, L. Ma, L.D. Van de Kar, F. Garcia, and D.L. Murphy Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice J Neurochem 84 2003 1256 1265
49. J.R. Martin, M. Bos, F. Jenck, J. Moreau, V. Mutel, and A.J. Sleight 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential J Pharmacol Exp Ther 286 1998 913 924
50. Masse F, Hascoet M, Bourin M. Alpha2-adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice. Behav Brain Res, 2005, in press.
51. Masse F, Hascoet M, Dailly E, Bourin M. Effect of nordrenergic ligands on the anxiolytic-like effect of (5-HT2A/2C agonist) in the four-plate test. Psychopharmacol (Berl), submitted for publication.
52. I.S. McGregor, and R.A. Dielenberg Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats Psychopharmacol (Berl) 147 1999 174 181
53. L.L. Melo, and M.L. Brando Involvement of 5-HT(1A) and 5-HT(2) receptors of the inferior colliculus in aversive states induced by exposure of rats to the elevated plus-maze test Behav Pharmacol 6 1995 413 417
54. A. Meneses 5-HT system and cognition Neurosci Biobehav Rev 23 1999 1111 1125
55. A. Meneses Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism? Cell Mol Neurobiol 22 2002 675 688
56. M.J. Millan The neurobiology and control of anxious states Prog Neurobiol 70 2003 83 244
57. M.J. Millan, F. Lejeune, and A. Gobert Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents J Psychopharmacol 14 2000 114 138
58. P.O. Mora, C.F. Netto, and F.G. Graeff Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze Pharmacol Biochem Behav 58 1997 1051 1057
59. K. Nakamura, and M. Kurasawa Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism Eur J Pharmacol 420 2001 33 43
60. B.A. Nic Dhonnchadha, M. Bourin, and M. Hascoet Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety Behav Brain Res 140 2003 203 214
61. B.A. Nic Dhonnchadha, M. Hascoet, P. Jolliet, and M. Bourin Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice Behav Brain Res 147 2003 175 184
62. B.A. Nic Dhonnchadha, N. Ripoll, F. Clenet, M. Hascoet, and M. Bourin Implication of 5-HT(2) receptor subtypes in the mechanism of action of antidepressants in the four plates test Psychopharmacol (Berl) 179 2005 418 429
63. K. Njung'e, and S.L. Handley Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents Br J Pharmacol 104 1991 105 112
64. B. Olivier, H.E. Molewijk, J.A. van der Heyden, R. van Oorschot, E. Ronken, and J. Mos Ultrasonic vocalizations in rat pups: effects of serotonergic ligands Neurosci Biobehav Rev 23 1998 215 227
65. E.S. Onaivi, C. Bishop-Robinson, N.A. Darmani, and E. Sanders-Bush Behavioral effects of (+/-)-1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test Life Sci 57 1995 2455 2466
66. E.A. Pehek, H.G. McFarlane, K. Maguschak, B. Price, and C.P. Pluto M100, 907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex Brain Res 888 2001 51 59
67. M. Pessia, Z.G. Jiang, R.A. North, and S.W. Johnson Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro Brain Res 654 1994 324 330
68. P.A. Pierce, and S.J. Peroutka Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex Psychopharmacol (Berl) 97 1989 118 122
69. N.K. Popova, A.V. Kulikov, D.F. Avgustinovich, and S.N. Shigantsov The characteristics of the brain serotonin system and anxiety in the C57BL and CBA mouse strains Zh Vyssh Nerv Deiat Im I P Pavlova 46 1996 348 354
70. R.H. Porter, K.R. Benwell, H. Lamb, C.S. Malcolm, N.H. Allen, and D.F. Revell Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells Br J Pharmacol 128 1999 13 20
71. M. Rinaldi-Carmona, C. Congy, V. Santucci, J. Simiand, B. Gautret, and G. Neliat Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist J Pharmacol Exp Ther 262 1992 759 768
72. N. Ripoll, B.A. Nic Dhonnchadha, V. Sebille, M. Bourin, and M. Hascoet The four-plates test-retest paradigm to discriminate anxiolytic effects Psychopharmacol (Berl) 180 2005 73 83
73. R.J. Rodgers, N.J. Johnson, J.C. Cole, C.V. Dewar, G.R. Kidd, and P.H. Kimpson Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade Pharmacol Biochem Behav 54 1996 41 50
74. L.E. Rueter, C.A. Fornal, and B.L. Jacobs A critical review of 5-HT brain microdialysis and behavior Rev Neurosci 8 1997 117 137
75. N. Santana, A. Bortolozzi, J. Serrats, G. Mengod, and F. Artigas Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex Cereb Cortex 14 2004 1100 1109
76. R. Schreiber, M. Brocco, V. Audinot, A. Gobert, S. Veiga, and M.J. Millan (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists J Pharmacol Exp Ther 273 1995 101 112
77. R. Schreiber, C. Melon, and J. De Vry The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test Psychopharmacol (Berl) 135 1998 383 391
78. R.Y. Shen, and R. Andrade 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus J Pharmacol Exp Ther 285 1998 805 812
79. D.M. Sokal, A.S. Giarola, and C.H. Large Effects of GABA(B), 5-HT(1A), and 5-HT(2) receptor stimulation on activation and inhibition of the rat lateral amygdala following medial geniculate nucleus stimulation in vivo Brain Res 1031 2005 141 150
80. M. Titeler, R.A. Lyon, and R.A. Glennon Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens Psychopharmacol (Berl) 94 1988 213 216
81. V.A. Vaidya, R.M. Terwilliger, and R.S. Duman Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus Neurosci Lett 262 1999 1 4
82. P. Weikop, J. Kehr, and J. Scheel-Kruger The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus J Psychopharmacol 18 2004 395 403
83. D.L. Willins, and H.Y. Meltzer Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats J Pharmacol Exp Ther 282 1997 699 706
84. C. Wu, E.J. Yoder, J. Shih, K. Chen, P. Dias, and L. Shi Development and characterization of monoclonal antibodies specific to the serotonin 5-HT2A receptor J Histochem Cytochem 46 1998 811 824
85. J. Wu, G.L. Kramer, M. Kram, M. Steciuk, I.L. Crawford, and F. Petty Serotonin and learned helplessness: a regional study of 5-HT1A, 5-HT2A receptors and the serotonin transport site in rat brain J Psychiatr Res 33 1999 17 22
86. Z. Yan Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications Mol Neurobiol 26 2002 203 216